Glaxo strikes swine flu deal with British govt

The British government today said it was cutting its swine flu vaccine deal with GlaxoSmithKline in a move that will see it pay two thirds of the original value, but receive just over a third of the doses.

In a mutually agreed deal, the Department of Health said the UK order with Glaxo would now be capped at 34.8 million doses, including those already received, out of a total original order of 90 million doses from the firm.